Core Viewpoint - The recent approval by regulatory authorities for banks to abolish their supervisory boards and transfer their functions to the audit committee of the board is a significant shift in corporate governance within the banking sector in China [1][2][3] Group 1: Regulatory Changes - Over ten banks have announced the approval to abolish their supervisory boards, including prominent banks such as Wuxi Rural Commercial Bank, Changshu Bank, Zhengzhou Bank, and Shanghai Bank [1] - The new Company Law, effective from July 1, 2024, allows joint-stock companies to establish an audit committee composed of directors to perform the functions of the supervisory board, eliminating the need for a supervisory board [2] - The National Financial Supervision Administration's notification in December 2025 further clarifies that financial institutions can set up an audit committee in accordance with their articles of association, thereby not requiring a supervisory board [2] Group 2: Historical Context and Implications - The supervisory board system was introduced in the 1990s in China's banking sector, modeled after the German system, to establish an independent supervisory layer [3] - The original intent of the supervisory board was to act as a supervisor in corporate governance, ensuring compliance and asset safety, but it has often struggled to fulfill this role effectively [3] - The transition to an audit committee, typically composed of directors with financial and risk management backgrounds, is expected to enhance governance efficiency by integrating supervisory functions into the decision-making core of the board [3]

Group 1: China Construction - The total new contracts signed by China Construction from January to October reached 3.61 trillion yuan, representing a year-on-year increase of 1% [1] Group 2: Changyuan Power - Changyuan Power's subsidiary received approval for the 100MW wind power project in Songzi, Hubei [2] Group 3: China Metallurgical Group - China Metallurgical Group reported a total new contract amount of 845.07 billion yuan from January to October, a decrease of 11.8% year-on-year, while overseas contracts increased by 7.3% to 71.16 billion yuan [4] Group 4: Shapuaisi - Shapuaisi received approval for clinical trials of deoxycorticosterone ketone solution, intended for use during cataract surgery [5] Group 5: Jianfeng Group - Jianfeng Group's subsidiary received approval for clinical trials of a new drug for treating advanced non-squamous non-small cell lung cancer [7] Group 6: Chongqing Steel - Chongqing Steel announced the resignation of its president Meng Wenwang due to work adjustments [8] Group 7: Tianma Technology - Tianma Technology reported an output of approximately 1732.99 tons of eel in October, with a total output of about 15218.73 tons from January to October [10] Group 8: Qingyuan Co. - Qingyuan Co.'s controlling shareholder reduced holdings of convertible bonds by 685,400 units, accounting for 13.71% of the total issuance [11] Group 9: Spring Airlines - Spring Airlines reported a passenger turnover of 506,200.49 million kilometers in October, a year-on-year increase of 20.06% [12] Group 10: China Merchants Port - China Merchants Port reported a total container volume of 17.1714 million TEUs from January to October, a year-on-year increase of 5.1% [13] Group 11: Yangdian Technology - Yangdian Technology announced a change in control following a share transfer [15] Group 12: Wanfu Biology - Wanfu Biology decided to postpone the implementation of its Knowledge City production base project [16] Group 13: Iwu Biology - Iwu Biology terminated the research project for a specific drug, which will reduce its 2025 net profit by approximately 333.79 million yuan [17] Group 14: Hainan Rubber - Hainan Rubber received an insurance payout of 22.9241 million yuan due to revenue loss from rubber price fluctuations [19] Group 15: Xinjiang Tianye - Xinjiang Tianye plans to establish a joint venture with Tianchi Energy to develop coal chemical projects [20] Group 16: China Coal Energy - China Coal Energy's executive director and president Zhao Rongzhe resigned due to reaching retirement age [22] Group 17: Huading Co. - Huading Co. received approval for a stock issuance to specific investors from the Shanghai Stock Exchange [24] Group 18: Zhongmu Co. - Zhongmu Co. decided to waive its right of first refusal for a 4.04% stake in a subsidiary [25] Group 19: Tianlong Co. - Tianlong Co. reported that its subsidiary's stock issuance was approved by the Beijing Stock Exchange [26] Group 20: Hualan Co. - Hualan Co.'s subsidiary plans to invest 20 million yuan in a biotechnology company [27] Group 21: Haichen Pharmaceutical - Haichen Pharmaceutical received a drug registration certificate for a new injection [28] Group 22: Aier Eye Hospital - Aier Eye Hospital plans to invest 300 million yuan in wealth management products [29] Group 23: Xiamen Engineering Machinery - Xiamen Engineering Machinery announced a planned share reduction by a major shareholder [30] Group 24: Guotai Group - Guotai Group successfully acquired 100% of a mining technology company for 110.1 million yuan [31] Group 25: Wanfeng Aowei - Wanfeng Aowei reached a settlement regarding an arbitration matter with a subsidiary [32] Group 26: Taihe Technology - Taihe Technology is undergoing technical upgrades for its ethylene carbonate project [33] Group 27: Renhe Pharmaceutical - Renhe Pharmaceutical's controlling shareholder plans to reduce holdings by 0.21% [34] Group 28: Changshu Bank - Changshu Bank's second-largest shareholder increased its stake to 3.98% [35] Group 29: Overseas Chinese Town A - Overseas Chinese Town A reported a 57% decrease in contract sales in October [36] Group 30: Canadian Solar - Canadian Solar's controlling shareholder expects total revenue of 1.3 to 1.5 billion USD in Q4 2025 [38] Group 31: Zhonggong Education - Zhonggong Education's controlling shareholder's shares will be auctioned due to a loan dispute [40] Group 32: Aikexibo - Aikexibo's shareholders plan to reduce their holdings by up to 3% [42] Group 33: Wanhua Chemical - Wanhua Chemical's shareholder plans to reduce holdings by up to 0.5% [44] Group 34: Jujie Microfiber - Jujie Microfiber's controlling shareholder plans to reduce holdings by up to 2% [45] Group 35: Wangsu Technology - Wangsu Technology's shareholder plans to reduce holdings by up to 1% [46] Group 36: Tianli Lithium Energy - Tianli Lithium Energy received a patent for lithium-ion battery materials [47] Group 37: Heshun Electric - Heshun Electric won a 40 million yuan project for energy storage services [49] Group 38: Changchun High-tech - Changchun High-tech's subsidiary received FDA approval for a clinical trial of a new drug [51] Group 39: Dongrui Co. - Dongrui Co. received an additional export quota for live pigs to Hong Kong [52] Group 40: Zhongwei Co. - Zhongwei Co. set the H-share issuance price at 34 HKD per share [53] Group 41: Fospower Technology - Fospower Technology plans to invest in a lithium sulfide project with partners [54]

Group 1 - Duopule plans to reduce its shareholding by no more than 1%, amounting to a maximum of 619,000 shares [1] - Lideman intends to acquire 70% of Xiansheng Xiangrui for 1.733 billion yuan, focusing on tuberculosis screening and diagnosis [2] - Huahuan Group is planning a change in control, leading to a temporary suspension of its stock [3] Group 2 - Dongbai Group clarifies it does not engage in duty-free business, maintaining normal operations [4][5] - Changsheng Bearing's actual controller plans to reduce holdings by up to 1.99%, equating to 5.94 million shares [6][7] - Jidian plans to invest 5.698 billion yuan in the Baicheng Phase II coal power project, a key initiative under the national "14th Five-Year Plan" [9][10] Group 3 - Baoneng New Energy reports completion of land-based works for the expansion of the Lufeng Qiaohai Bay Power Plant [11][12] - Changshu Bank proposes to appoint Lu Dingchang as the new president and chief compliance officer [13][14] - Kangqiang Electronics plans to reduce its shareholding by no more than 1%, totaling up to 3.7526 million shares [14] Group 4 - Jilin Chemical Fiber intends to reduce its holdings by up to 2%, equating to 49.1774 million shares [15][16] - CanSino's inhaled tuberculosis vaccine has commenced Phase I clinical trials in Indonesia [17][18] - ST Dongyi's stock has been suspended for review due to significant price fluctuations [19] Group 5 - ST Yatai plans to reduce its holdings by up to 1.98%, totaling 6.4 million shares [20] - Huaren Pharmaceutical intends to reduce its holdings by up to 3%, equating to 35.4663 million shares [21] - Jianglong Shipbuilding's controlling shareholder plans to reduce holdings by up to 2%, amounting to 7.5534 million shares [22] Group 6 - Borui Pharmaceutical's BGM1812 injection has received approval for clinical trials targeting overweight or obesity [23][24] - ST Zhongzhu announces the transfer of 10.38% of its shares, totaling approximately 403 million yuan [25][26] - Shenzhou Digital plans to establish an employee stock ownership plan with a maximum fundraising of 360 million yuan [27][28] Group 7 - Kaichuang Electric plans to establish a joint research center with Tsinghua University, focusing on embodied intelligence [29] - Daming City intends to acquire 19.43% of Baicaibang for 694 million yuan, specializing in communication solutions [29]

Regulatory Voice - The People's Bank of China reported that by the end of October, the balance of RMB deposits reached 325.55 trillion yuan, a year-on-year increase of 8% [1] - The total balance of domestic and foreign currency deposits was 332.92 trillion yuan, growing by 8.3% year-on-year [1] - In the first ten months, RMB deposits increased by 23.32 trillion yuan, with household deposits rising by 11.39 trillion yuan [1] Industry Focus - The establishment of Xinjiang Rural Commercial Bank has been approved, marking a significant step in China's rural financial reform [2] - Xinjiang becomes the sixth province to have a provincial-level rural commercial bank, with expected assets exceeding 700 billion yuan upon opening [2] Corporate Dynamics - Xinyin Investment, a wholly-owned subsidiary of Industrial Bank, has been approved to commence operations with a registered capital of 10 billion yuan [7][8] - This marks the sixth licensed Asset Investment Company (AIC) approved in the industry, and the first initiated by a joint-stock bank [8] Financial Personnel - Changshu Bank announced a major management reshuffle, with the resignation of its president and vice president due to work changes [9] - The bank plans to appoint Lu Dingchang as the new president and chief compliance officer, alongside two new vice presidents [9] - Additionally, local state-owned shareholders have increased their stake in Changshu Bank, acquiring 561.93 million shares, raising their total holding to 3.98% [9] Industry Trends - Domestic private banking continues to thrive, with several banks reporting double-digit growth in private banking clients [3] - Ping An Bank has surpassed 100,000 private banking clients, joining the "100,000 Club" alongside six other banks [3] - A trend of integrating and shutting down independent credit card and direct banking apps is emerging among banks, reflecting a shift towards digital transformation [4] - Many small and medium-sized banks are actively removing long-term deposit products to optimize their liability structure and reduce costs [6]

21世纪经济报道记者 吴霜 在众多银行中，有一家银行历任行长的履历出奇得一致。 近日，常熟银行密集发布公告，迎来了三位新的高管人选，其中包含一位行长和两位副行长。其中，这 位行长又是一位成长于常熟银行基层的领导，此外，他还格外的年轻，出生于1986年，现年39岁，再次 刷新上市银行最年轻行长的纪录。 常熟银行公告显示，其董事会会议已经通过了聘任陆鼎昌为行长兼首席合规官的议案，并增补陆鼎昌为 第八届董事会执行董事。 而其前任包剑同样起步于常熟银行，从柜员一步步做到行长的位置，其间还曾在南京银行和江南农商行 短暂任职。 陆鼎昌1986年8月出生，长期在常熟银行任职。历任常熟银行小额贷款中心信贷员、总经理助理，小微 金融总部副总经理，公司银行部副总经理，邗江支行行长，扬州分行副行长兼邗江支行行长，普惠金融 部总经理，小微金融总部兼普惠金融部总经理，党委委员、副行长兼普惠金融部总经理。现任本行党委 副书记、副行长。 可以看出，陆鼎昌长期深耕小微金融领域，曾获全国银行业金融机构小微企业金融服务先进个人，与常 熟银行的优势和重点业务——小微信贷相契合。 张康德历任常熟理工学院化学与材料工程学院辅导员、团委书记、主任科员； ...

东方证券研报指出，利息净收入增速环比回升，利润增速维持高位。截至25Q3，常熟银行营收、 PPOP、归母净利润增速（累计同比增速，下同）分别较25H1-1.9pct、-2.0pct和-0.7pct至8.2%、10.1%和 12.8%。利润增速维持高位，净息差收窄显著放缓。推测新发放贷款定价或阶段性平稳，同时在活期化 趋势延续、久期压缩的环境下，计息负债成本率有可观改善。9月，常熟银行首次实施中期分红，且分 红比例较24年全年提高5.5pct至25.27%（归母净利润口径）。参考可比公司平均估值，由于公司ROE优 势依旧明显，给予10%溢价，即25年0.84倍PB，对应合理价值8.12元/股，维持"买入"评级。 ...

Investment Rating - The industry investment rating is "Market Weight" indicating that the industry index is expected to perform within -10% to 10% relative to the CSI 300 index over the next six months [26]. Core Insights - The report highlights a slowdown in credit and government financing, with new policy tools being introduced to stimulate lending. The total social financing stock grew by 8.5% year-on-year, while RMB loans increased by 6.3% year-on-year [4][5]. - The report emphasizes the importance of new policy tools that are expected to have a positive impact on credit growth, particularly in sectors like technology innovation and infrastructure [4][5]. - The report notes that the loan interest rates have remained stable, with the average interest rate for new corporate loans and personal housing loans both at approximately 3.1% [4][5]. Summary by Sections Credit and Financing Trends - As of October, the total social financing stock increased by 8.5% year-on-year, while RMB loans grew by 6.3% year-on-year. The M2 and M1 money supply grew by 8.2% and 6.2% respectively [4]. - New corporate loans decreased by 201 billion RMB year-on-year, reflecting weak demand in the real economy [4]. - The report indicates that the introduction of new policy tools, particularly in the form of entrusted loans, is aimed at stabilizing credit growth [4][5]. Loan and Deposit Dynamics - The report notes a seasonal outflow of deposits post-quarter, with both M2 and M1 growth rates declining. This is attributed to seasonal factors and a slowdown in credit and government bond issuance [4]. - The average interest rates for new loans have stabilized, which is expected to ease pressure on interest margins in 2025 compared to 2024 [4][5]. Investment Recommendations - The report suggests focusing on the impact of new policy tools on credit dynamics in the upcoming months, particularly in the context of government financing becoming less robust [5]. - It is recommended to monitor the banking sector's performance, as the dividend advantage of the banking sector is expected to attract medium to long-term capital [5].

Investment Rating - The report does not explicitly state an investment rating for the banking sector, but it provides detailed insights into dividend yields and distribution processes, which can inform investment decisions. Core Insights - The report outlines the latest dividend yields and mid-term dividend processes for A and H shares of listed banks, emphasizing the importance of accurately calculating dynamic dividend yields to avoid discrepancies across periods [1][2]. - It details the two processes for mid-term dividends following the 2023 revision of the regulatory guidelines, highlighting the conventional and simplified processes for implementing mid-term dividends [2]. - The report provides a comprehensive overview of key dates related to dividend distribution for both A and H shares, including the importance of purchasing shares before the ex-dividend date to qualify for dividends [3][4]. Summary by Sections Dynamic Dividend Yield Calculation - A simplified yet accurate method for calculating dynamic dividend yield is introduced, defined as "rolling 12-month EPS * cash dividend rate / share price," which helps avoid issues related to overlapping or missing annual and mid-term dividends [1]. - The report calculates the cash dividend rate using a standardized approach across different banks, resulting in a clear comparison of dividend yields as of November 13, 2025 [1]. Mid-Term Dividend Processes - The report explains the two processes for mid-term dividends: the conventional process requiring shareholder approval and a simplified process allowing for quicker implementation [2]. - The simplified process is designed to enhance flexibility for companies in distributing mid-term dividends, thereby improving shareholder returns [2]. Dividend Distribution Key Dates - For A shares, investors must purchase shares before the ex-dividend date to receive dividends on the same day, while H shares typically see a delay of about one month for dividend payments [3][4]. - The report outlines the differences in the dividend distribution timeline between A and H shares, emphasizing the need for investors to be aware of these timelines to maximize their returns [3][4]. Mid-Term Dividend Progress - As of November 13, 2025, 31 A-share banks have confirmed mid-term dividends, while 11 H-share banks have also confirmed their dividend distributions [9][11]. - The report categorizes banks based on their dividend status, detailing those that have implemented dividends, those that are pending, and those that have opted not to distribute dividends [9][10][11]. - It highlights that the end of 2025 and early 2026 is expected to be a peak period for mid-term dividend distributions, suggesting potential investment opportunities for dividend-seeking investors [11].

Investment Rating - The report maintains a "Buy" rating for the company [3][5]. Core Insights - The company's net profit growth is projected to be 12.1% in 2025, 10.5% in 2026, and 10.1% in 2027, with a corresponding book value per share (BVPS) of 9.62, 10.85, and 12.21 yuan respectively [3]. - The current stock price corresponds to a price-to-book (PB) ratio of 0.75X for 2025, 0.67X for 2026, and 0.59X for 2027, indicating a valuation premium due to the company's strong return on equity (ROE) [3]. - The reasonable value per share is estimated at 8.12 yuan, reflecting a 10% premium over comparable companies [3]. Financial Performance Summary - For 2023, the company reported total revenue of 9,870 million yuan, with a year-on-year growth of 12.1% [4]. - Operating profit for 2023 was 4,053 million yuan, showing a significant year-on-year increase of 49.8% [4]. - The net profit attributable to the parent company for 2023 was 3,282 million yuan, representing a year-on-year growth of 19.6% [4]. - The earnings per share (EPS) for 2023 is reported at 0.99 yuan [4]. - The company’s total assets and loan amounts grew by 10.9% and 7.1% year-on-year respectively as of Q3 2025 [9]. - The net interest margin showed a minimal contraction of 1 basis point, the smallest decline since the second half of 2023 [9]. Dividend Policy - The company has implemented a mid-term dividend for the first time, increasing the payout ratio to 25.27% of net profit attributable to the parent company, up by 5.5 percentage points from the previous year [9].

Core Insights - The banking wealth management distribution market has seen significant growth since 2025, with many banks rapidly increasing the number of wealth management products they distribute [2][3]. Distribution Growth - From the top 20 banks by incremental growth, at least 14 banks have added over 1,000 new wealth management products, with 10 banks doubling their product offerings compared to the end of last year, and some even exceeding a 200% increase [3][4]. - Notable banks include: - Industrial Bank: 7,635 products, a 53% increase [4] - Beijing Bank: 4,236 products, an 80% increase [4] - Changshu Rural Commercial Bank: 2,130 products, a 211% increase [4]. Performance Metrics - The wealth management distribution revenue for major banks has also increased significantly: - China Merchants Bank reported a wealth management distribution income of 7.014 billion yuan, an 18.14% year-on-year increase [8]. - Beijing Bank's distribution scale has exceeded last year's total, with a fee income growth of over 10% [8]. - Changshu Rural Commercial Bank's commission income grew over 57% in the third quarter, attributed to increased fees from agency wealth management services [8]. Market Dynamics - The wealth management distribution market has reached a new high, surpassing 32 trillion yuan, with 139 million investors holding wealth management products, a 12.7% year-on-year increase [10]. - The average annualized yield for cash management products is 1.33%, while fixed-income products yield 2.42%, indicating a competitive advantage over traditional savings [11]. Regulatory Changes - The implementation of the "Commercial Bank Agency Sales Business Management Measures" on October 1 has clarified standards and processes for distribution business [16]. - The market is witnessing a shift as many banks, especially smaller ones, are aggressively entering the wealth management distribution space to capture market opportunities amid narrowing interest margins [9][10]. Future Trends - The demand for retirement wealth management products is expected to grow, especially following the recent expansion of pilot programs for retirement financial products across the country [24][27]. - The market is preparing for increased competition as banks look to enhance their service capabilities and product offerings in response to evolving customer needs [23][24].